Oralis SB Granted Oral Health Claim in Canada

636002872354088521021.jpg

31 May 2016 --- Canadian company Lallemand Health Solutions (LHS) has announced that their probiotic formula Oralis SB has been recognized for its benefits in dental health management by the Canadian Health Authorities, based on four randomized trials.

The following health claim has been approved by Health Canada: “Helps promote dental health through the control of Streptococcus mutans growth and plaque formation when used twice daily.”
 
In addition, the solution bears generic probiotic claims: Helps support intestinal/gastrointestinal health. Could promote a favorable gut flora. Source of probiotics.
 
The randomized trials submitted to the Canadian authorities and gathering a total of 330 children and 52 adults showed the following conclusions:
• Jindal et al. (2011): Oralis SB significantly reduces salivary S. mutans count as compared to a placebo in children. The authors concluded that Oralis SB “might be used as a suitable, easy and safe method for anti-caries prevention.”
• Jothika et al. (2015): Oralis SB used as mouthwash significantly reduces the count of cariogenic bacteria S. mutans found in the plaque in adults as compared to placebo and with similar efficacy than traditional antiseptic solutions (chlorhexidine and sodium fluoride mouthwashes).
• Thakkar et al., (2013): Oralis SB significantly reduces dental plaque formation in children, when compared to placebo, but also to chlorhexidine antiseptic mouthwash. It was concluded that Oralis SB “can be viewed as potential alternative to chlorhexidine mouthrinse for prevention of periodontal disease”.
• Purunaik et al. (2014): Oralis SB significantly reduces dental plaque formation in children as compared to placebo and chlorhexidine, and is even significantly more effective than chlorhexidine on gingivitis.
 
Altogether, these results indicate that this specific combination of Lactobacillus rhamnosus Rosell-11, Lactobacillus helveticus Rosell-52, Bifidobacterium longum Rosell-175 and Saccharomyces boulardii yeast represent a natural and effective approach to dental health prevention.
 
LHS has bases in more than 60 countries across 5 continents. Oralis SB is part of LHS’s portfolio of probiotics for Oral Health. Lallemand Inc. specializes in the development, production and marketing of yeast and bacteria, as well as other ingredients linked to these microorganisms or their markets.

Related Articles

Nutrition & Health News

AI: Nuritas explores potential health benefits during Future of Nutrition Summit

13 Dec 2017 --- Biotechnology company Nuritas has innovative plans for using artificial intelligence (AI) to relieve the potential burden of future global health issues. These plans were outlined during its Future of Nutrition Summit held the day before FiE 2017 in Frankfurt, during which Nuritas Commercial Manager Neil Foster outlined the company’s use of AI for data mining for bioactive peptides, specific molecules with “tremendous” health benefits.

Business News

Vitafoods Europe to examine mainstreaming of personalized nutrition

13 Dec 2017 --- One of the major issues to be discussed at Vitafoods Europe 2018 will be how personalized nutrition can break out of its niche and achieve mass market appeal, the organizers of the global nutraceutical event have announced. Advances in genomics and wearable technology have created new opportunities for products tailored to individual consumers. And in a new poll conducted by the organizers, personalized nutrition ranks as one of the most important industry trends for 2018, behind only clean label and scientifically supported health claims.

Nutrition & Health News

NattoPharma enters Chinese market with new MenaQ7 launch

30 Nov 2017 --- NattoPharma has participated in a launching conference commemorating the first product introduced in China featuring MenaQ7 Vitamin K2 as MK-7. During the event, FishBurg, a Chinese dietary supplement producer in the calcium/vitamin D3 (VD3) segment, signed a partnership and supply agreement with NattoPharma and officially launched its new Blue Hat-registered calcium/VD3/MenaQ7 Vitamin K2 supplement for bone health to the Chinese market.

Nutrition & Health News

Four claims in one vegan capsule: Polaris launches algal DHA omega 3 in softgel

21 Nov 2017 --- Polaris is launching its ultra-stable algal DHA omega 3 in vegan softgel format, enabling it to offer four EFSA claims in one capsule, the company reports. Each capsule is said to deliver an optimal 250mg of DHA omega 3 from microalgae in a 100 percent plant-based shell, making it the ideal solution for consumers seeking a vegan or vegetarian alternative to gelatin capsules.

Nutrition & Health News

Yerba mate supplementation's anti-obesity effect supported by study

16 Nov 2017 --- Researchers have shown that use of the dietary supplement yerba mate over an extended period had significant effects on body weight and weight gain and was associated with lower levels of blood lipids and insulin in obese mice fed a high-fat diet. In recent years, the popularity of yerba mate has grown steadily in NPD, with an increasing number of food, beverage and supplement product launches with a variety of health claims featuring this South American plant.

More Articles
URL : http://www.nutritioninsight.com:80/news/oralis-sb-granted-oral-health-claim-in-canada.html